MSB 5.24% $1.11 mesoblast limited

(NON-TRADING) COVID-19 ARDS DISCUSSION

  1. 2,126 Posts.
    lightbulb Created with Sketch. 1777
    Hey all!

    As opposed to the trading chatter that's permeating all the other threads, I thought that it would be useful to have a thread where we could exchange ideas about Remestemcel-L's MOA and the possible interaction in-vivo in the treatment of COVID-19 ARDS.

    As a primer, here is the recent slide showing how Rem-L responds to inflammation.https://hotcopper.com.au/data/attachments/2394/2394255-59b3e1d5d6a55ffd2556d34e0563abe7.jpg

    My question is, in C-19 ARDS, patients have displayed elevated serum cytokines (particularly IL-6 and TNFa) among other things. Do you reckon there are factors in play that Rem-L might modulate?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.